AllFocal Optics revolutionizes display technology through groundbreaking nanophotonic solutions.
Infinitopes is a cancer research organization focused on enhancing the immune system to prevent metastases and ultimately save lives. The company develops healthcare systems and therapeutic designs that integrate advanced tumor target identification technologies with efficient vector delivery systems. By applying this innovative platform in early-stage clinical trials, Infinitopes aims to improve patient outcomes in the fight against cancer and tumors, offering new hope for those affected by these diseases.
Xampla Ltd is a cleantech company based in Cambridge, United Kingdom, that specializes in developing plant protein-based materials as sustainable alternatives to traditional plastics and microplastics. Founded in 2018, Xampla produces a variety of products, including microcapsules, films, coatings, and beads, which are designed for use in sectors such as food, cosmetics, household products, animal feed, packaging, and medical applications. All materials are biodegradable and biocompatible, made without synthetic ingredients, allowing clients to create environmentally friendly products that minimize pollution.
Spotta Ltd is a company that specializes in developing smart pest control systems aimed at the hotel and lodging industry, focusing on the early detection of bed bugs. Founded in 2018 and headquartered in Cambridge, United Kingdom, Spotta offers a battery-powered insect monitoring sensor that alerts users to potential bed bug infestations. This innovative technology analyzes detection data to ensure that notifications pertain only to genuine incidents, allowing hotels to proactively prevent bed bugs from spreading and facilitating more efficient and cost-effective treatment options. By leveraging these systems, lodging providers can enhance guest satisfaction and maintain a pest-free environment.
Nu Quantum Ltd is a company focused on developing quantum photonics hardware and infrastructure essential for scaling quantum computers. Founded in 2018 and based in Cambridge, United Kingdom, the company specializes in creating solutions that interconnect quantum computing cores into large distributed clusters. Its offerings include photon sources and detectors, as well as systems for quantum cryptography that enable secure key exchanges. Nu Quantum is also engaged in producing nano-engineered materials that facilitate light generation at the quantum level and ultra-sensitive light detection. By partnering with leading quantum computing companies, governments, and research institutions, Nu Quantum aims to advance the development of entangled qubit networks and accelerate the creation of multi-core quantum supercomputers and quantum data centers.
Strolll is a digital health startup focused on creating solutions to enhance mobility for individuals with neurological disorders. The company develops extended reality digital therapeutics that empower movement therapy through innovative approaches. Its offerings include augmented reality services designed for cueing therapy and gamified exercise, aimed at improving gait and balance while reducing the risk of falls for patients with conditions such as Parkinson's disease. By providing these therapeutic tools, Strolll enables individuals to better manage their neurological disorders and improve their overall quality of life.
Pencil Biosciences is focused on creating an innovative genome modulation platform that addresses the limitations of existing gene-editing technologies. By developing a programmable tool for genome modulation, the company aims to provide new therapeutic options for patients suffering from rare diseases. This technology is designed to have a broad impact, allowing medical professionals to navigate the complexities of gene editing more effectively. Through its advancements, Pencil Biosciences seeks to enhance the capabilities of gene-editing applications in the medical field.
RoboK is a computer vision startup based in Cambridge, United Kingdom, founded in 2017. The company specializes in designing and developing simultaneous localization and mapping (SLAM) algorithms and advanced 3D sensing technologies tailored for automotive and industrial applications, including autonomous driving and machine automation. RoboK focuses on enhancing safety and performance in industrial workplaces through innovative, privacy-preserving technology that optimizes the capabilities of existing CCTV systems. By transforming visual data from large-scale transport and logistics infrastructures into actionable insights, RoboK collaborates with major operators in critical sectors to deliver enhanced object detection, classification, and tracking. The company aims to maximize the value of visual data, turning passive surveillance systems into proactive tools for efficiency and safety.
PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery of vital new medicines.
NunaBio is a privately-owned DNA development company based in England, United Kingdom. The company specializes in creating a variety of chemical and biological technologies and products, including long and short deoxyribonucleic acid (DNA) products available in microgram to gram scales. NunaBio is involved in contract research and development, as well as manufacturing services, offering expertise in cell therapies, vaccines, diagnostics, and gene therapies. Additionally, the company focuses on advanced DNA biosensing and associated consumables, supporting healthcare professionals in their efforts to treat patients effectively.
Cambridge GaN Devices specializes in the development and commercialization of gallium nitride (GaN) power devices aimed at improving energy efficiency in electronic applications. The company offers a variety of GaN-based semiconductor products that enhance power conversion and minimize energy loss across different systems. These advanced devices find applications in sectors such as renewable energy, electric vehicles, and consumer electronics, supporting the shift towards more sustainable technologies. Cambridge GaN Devices focuses on creating transistors that are faster, more compact, and more efficient than traditional silicon alternatives, thereby enabling industries to utilize tailored semiconductors for critical applications. The company collaborates with industry partners to promote innovation and facilitate the integration of its technology into the power semiconductor market.
Kalium Health Ltd is a company focused on improving kidney care through innovative medical technology. Based in Cambridge, United Kingdom, it designs and manufactures a finger-prick blood test specifically for measuring blood potassium concentration. This test aims to facilitate early treatment for patients, reducing the complications and costs associated with traditional testing methods. By leveraging advanced electrolyte sensing technology, Kalium Health provides patients with accurate, real-time data essential for managing cardiorenal diseases. The company’s first product addresses a significant risk in kidney disease, a condition that imposes substantial financial burdens on healthcare systems. With a clear regulatory pathway and a targeted market strategy, Kalium Health is poised to transform patient care and enhance outcomes for millions affected by kidney disease.
Semarion is a spin-out from the Cavendish Laboratory at the University of Cambridge, specializing in drug discovery and cell microcarrier technology. The company aims to enhance the process of drug screening by utilizing innovative materials and techniques from the microchip industry combined with cell biology. Its platform features ultra-miniaturized, magnetically steerable microcarriers designed to support small colonies of cells, which facilitates advanced assaying workflows and new experimental approaches. This technology is particularly focused on identifying GPCR-targeting oncology drugs, addressing significant gaps in medical needs and accelerating the pace of drug development.
Porotech is a spin-out from the University of Cambridge that specializes in the development of gallium nitride (GaN) semiconductor technologies. Co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver, the company focuses on creating energy-efficient wide-bandgap semiconductors through advanced material technologies. By harnessing the potential of GaN, Porotech aims to enhance the efficiency of light-emitting diodes and various electronic devices, thereby contributing to innovations in the electronics industry.
Cambridge GaN Devices specializes in the development and commercialization of gallium nitride (GaN) power devices aimed at improving energy efficiency in electronic applications. The company offers a variety of GaN-based semiconductor products that enhance power conversion and minimize energy loss across different systems. These advanced devices find applications in sectors such as renewable energy, electric vehicles, and consumer electronics, supporting the shift towards more sustainable technologies. Cambridge GaN Devices focuses on creating transistors that are faster, more compact, and more efficient than traditional silicon alternatives, thereby enabling industries to utilize tailored semiconductors for critical applications. The company collaborates with industry partners to promote innovation and facilitate the integration of its technology into the power semiconductor market.
Nu Quantum Ltd is a company focused on developing quantum photonics hardware and infrastructure essential for scaling quantum computers. Founded in 2018 and based in Cambridge, United Kingdom, the company specializes in creating solutions that interconnect quantum computing cores into large distributed clusters. Its offerings include photon sources and detectors, as well as systems for quantum cryptography that enable secure key exchanges. Nu Quantum is also engaged in producing nano-engineered materials that facilitate light generation at the quantum level and ultra-sensitive light detection. By partnering with leading quantum computing companies, governments, and research institutions, Nu Quantum aims to advance the development of entangled qubit networks and accelerate the creation of multi-core quantum supercomputers and quantum data centers.
Spotta Ltd is a company that specializes in developing smart pest control systems aimed at the hotel and lodging industry, focusing on the early detection of bed bugs. Founded in 2018 and headquartered in Cambridge, United Kingdom, Spotta offers a battery-powered insect monitoring sensor that alerts users to potential bed bug infestations. This innovative technology analyzes detection data to ensure that notifications pertain only to genuine incidents, allowing hotels to proactively prevent bed bugs from spreading and facilitating more efficient and cost-effective treatment options. By leveraging these systems, lodging providers can enhance guest satisfaction and maintain a pest-free environment.
Qkine Ltd, founded in 2016 and based in Cambridge, United Kingdom, specializes in manufacturing high-purity, animal-free growth factors, cytokines, and complex proteins. The company leverages proprietary protein production processes developed at the University of Cambridge, along with advanced protein engineering techniques, to create unique products that address key challenges in the stem cell, organoid, regenerative medicine, and cultivated meat sectors. Qkine's product line includes innovative offerings such as tag-free thermostable FGF-2, the first animal-free TGF beta 1 for chemically defined stem cell media, and animal-free HGF. With an active research and development pipeline and a commitment to quality, Qkine is ISO 9001:2015 certified, ensuring that it provides high-purity, bioactive proteins to support scientific advancements in life sciences.
Flusso Ltd, established in 2016 and located in Cambridge, United Kingdom, specializes in the development and manufacturing of flow sensor solutions. The company focuses on semiconductor technology, providing mass flow and air velocity sensors tailored for diverse industrial applications. Flusso's innovative sensor products are designed to meet proprietary technology needs across various sectors.
Porotech is a spin-out from the University of Cambridge that specializes in the development of gallium nitride (GaN) semiconductor technologies. Co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver, the company focuses on creating energy-efficient wide-bandgap semiconductors through advanced material technologies. By harnessing the potential of GaN, Porotech aims to enhance the efficiency of light-emitting diodes and various electronic devices, thereby contributing to innovations in the electronics industry.
Kalium Health Ltd is a company focused on improving kidney care through innovative medical technology. Based in Cambridge, United Kingdom, it designs and manufactures a finger-prick blood test specifically for measuring blood potassium concentration. This test aims to facilitate early treatment for patients, reducing the complications and costs associated with traditional testing methods. By leveraging advanced electrolyte sensing technology, Kalium Health provides patients with accurate, real-time data essential for managing cardiorenal diseases. The company’s first product addresses a significant risk in kidney disease, a condition that imposes substantial financial burdens on healthcare systems. With a clear regulatory pathway and a targeted market strategy, Kalium Health is poised to transform patient care and enhance outcomes for millions affected by kidney disease.
Nu Quantum Ltd is a company focused on developing quantum photonics hardware and infrastructure essential for scaling quantum computers. Founded in 2018 and based in Cambridge, United Kingdom, the company specializes in creating solutions that interconnect quantum computing cores into large distributed clusters. Its offerings include photon sources and detectors, as well as systems for quantum cryptography that enable secure key exchanges. Nu Quantum is also engaged in producing nano-engineered materials that facilitate light generation at the quantum level and ultra-sensitive light detection. By partnering with leading quantum computing companies, governments, and research institutions, Nu Quantum aims to advance the development of entangled qubit networks and accelerate the creation of multi-core quantum supercomputers and quantum data centers.
Closed Loop Medicine Ltd is a healthcare technology company based in Cambridge, United Kingdom, focused on developing innovative solutions that combine prescription drugs with digital therapies. Founded by a team of experienced healthcare professionals and life scientists, the company aims to optimize medication dosing through real-time feedback and linked behavioral therapy to enhance patient outcomes. Currently, Closed Loop Medicine is developing products targeting hypertension and insomnia, alongside a diverse pipeline addressing various chronic diseases. The company prioritizes the needs of both patients and clinicians in the design and development of its offerings, striving to integrate technology effectively within the healthcare system.
PervasID is developing a high reliability, wide area passive RFID system with the potential to provide location capability based on the EPC Class1 Gen2 standard. Spun out from research activity in the Engineering Department at the University of Cambridge, the technology is now successfully deployed in several field trials.
Undo Ltd. specializes in developing advanced debugging tools aimed at enhancing software development processes for professionals such as developers, software architects, and product managers. The company offers innovative solutions like LiveRecorder, which records and replays software execution, allowing users to identify and resolve programming errors effectively. Additionally, UndoDB serves as an interactive reversible debugger for C/C++ applications on Linux and Android platforms. By employing time travel debugging technology, Undo enables developers to gain insights into complex code, facilitating the diagnosis of new regressions, legacy bugs, and flaky tests prior to customer impact. The company primarily caters to industries including data management, networking, electronic design automation, and finance. Founded in 2005, Undo Ltd. operates from its headquarters in Cambridge, United Kingdom, and maintains an additional office in San Francisco, California.
Sorex Sensors Limited specializes in the design and manufacture of film bulk acoustic resonator (FBAR) technology-based micro-electro-mechanical system (MEMS) mass sensors for various industrial and consumer applications. Founded in 2017 and headquartered in the United Kingdom, the company fabricates its devices on silicon wafers, utilizing a thin film of piezoelectric material that resonates to detect mass changes accurately. These sensors are capable of measuring mass down to the femtogram range and can simultaneously monitor temperature with a resolution of 0.2 °C. Their small size and low power consumption make them suitable for diverse applications, including thin film metrology, particulate monitoring, and gas detection. Additionally, the surface of the sensors can be functionalized to selectively detect specific targets, enhancing their versatility in detecting harmful compounds in various environments, such as homes and workplaces.
Paragraf Ltd. is a UK-based company specializing in the development of graphene technology and the production of two-dimensional materials. Established in 2015, Paragraf focuses on creating graphene-based electronic devices, including magnetic sensors and biosensors, that are designed to enhance technological performance in various sectors such as electronics, energy, research, automation, and healthcare. The company employs contamination-free technology to ensure the production of high-purity graphene products that meet commercial quality standards. Paragraf's innovations aim to optimize process control, improve quality assurance, and facilitate monitoring of environmental and health conditions, thereby contributing to advancements in green energy generation and other critical applications.
Rovco Ltd is a company based in Bristol, United Kingdom, that specializes in underwater hydrographic survey and inspection services through the use of remotely operated vehicles (ROVs) and autonomous underwater vehicles (AUVs). Founded in 2015, Rovco serves the oil, gas, and renewables industries by providing advanced technologies that optimize the management and inspection of subsea assets. The company employs artificial intelligence and machine learning to enhance its inspection capabilities, including 3D photogrammetry, which generates detailed 3D models from high-resolution images. This technology allows clients to assess their subsea assets for damage, corrosion, and marine growth, facilitating early insights that inform engineering decisions and support preventative maintenance. By offering these services, Rovco helps clients reduce costs and mitigate risks associated with their subsea operations.
Closed Loop Medicine Ltd is a healthcare technology company based in Cambridge, United Kingdom, focused on developing innovative solutions that combine prescription drugs with digital therapies. Founded by a team of experienced healthcare professionals and life scientists, the company aims to optimize medication dosing through real-time feedback and linked behavioral therapy to enhance patient outcomes. Currently, Closed Loop Medicine is developing products targeting hypertension and insomnia, alongside a diverse pipeline addressing various chronic diseases. The company prioritizes the needs of both patients and clinicians in the design and development of its offerings, striving to integrate technology effectively within the healthcare system.
Audio Analytic Ltd. is a developer of sound recognition software focused on enhancing consumer products with advanced auditory capabilities. The company's offerings include the ai3™ analytics software, which classifies and recognizes various sounds, and additional products like Core Logger Lite for loudness detection and Sound Pack for sound signature detection. These technologies are designed for integration into a wide array of devices, including smart speakers, video doorbells, smartphones, and true wireless earbuds. By providing its software to original equipment manufacturers and chip providers, Audio Analytic aims to enable a greater understanding of sound context in consumer electronics. Founded in 2008 and headquartered in Cambridge, United Kingdom, with an office in San Francisco, the company serves sectors such as entertainment, communication, and acoustics.
Techspert is an expert network platform that leverages artificial intelligence to facilitate primary research and business intelligence across various sectors. Originally focused on healthcare, the company was founded by Graham and David, who recognized the challenges of connecting with the right experts. With the addition of co-founder Hari, they developed an AI-driven solution capable of analyzing and indexing extensive online content to create accurate expert profiles. This technology enables businesses to connect with key opinion leaders and obtain domain-specific insights efficiently. Techspert's team includes professionals with backgrounds in computer science, software development, and client relations, and the company currently serves large consultancies and private equity groups. Committed to democratizing access to knowledge, Techspert aims to revolutionize the way expertise is exchanged while adhering to core values of curiosity, empathy, commitment, and ambition.
Exonate is a privately held, early stage, biotech company spun out of the University of Nottingham that is focused on alternative splicing of Vascular Endothelial Growth Factor (VEGF) in ophthalmology. Exonate’s lead programme is focused on Diabetic Macular Oedema (DMO). A consequence of diabetic retinopathy, DMO, is swelling in an area of the retina called the macula and wet Age-Related Macular Degeneration (wAMD), which is the leading cause of vision loss in people aged 60 and older. The Company is founded on scientific excellence with strong links to Professor David Bates and his lab at Nottingham University specializing in the biology and biochemical pathways of VEGF splice variants. Exonate have developed small molecules that inhibit production of pro-angiogenic VEGF through selective inhibition of serine/threonine-protein kinase 1 (SRPK1)-mediated VEGF splicing. These inhibitors have already demonstrated superior efficacy as topical agents in preclinical models of wet AMD. Through a Wellcome Trust funded project, Exonate has completed an optimization programme and has nominated a pre-clinical candidate drug with optimal characteristics. During the second quarter of 2020 regulatory toxicology and safety pharmacology studies have taken place. This is to support the successful application to the regulatory authorities for clinical evaluation. Exonate is led by an experienced, international management team that has previously worked together with cross-disciplinary experience in medicine and drug development, as well as successful fundraising for early stage companies. About Diabetic Macular Oedema (DMO)*: DMO is the build-up of fluid (Oedema) in a region of the retina called the macula. The macula is important for the sharp, straight-ahead vision that is used for reading, recognizing faces, and driving. DMO is the most common cause of vision loss among people with diabetic retinopathy. About half of all people with diabetic retinopathy will develop DMO and although it is more likely to occur as diabetic retinopathy worsens, DMO can happen at any stage of the disease. About wet Age-Related Macular Degeneration (wet AMD): Today, wet AMD is a leading cause of vision loss in people aged 60 years or older and affects more than 30 million patients worldwide, over 200,000 of those in the UK alone. If untreated patients are likely to lose sight in the affected eye within 24 months of disease onset. The main currently available treatment options for DMO and wet AMD are: • anti-VEGF antibody drugs – to prevent the growth of new blood vessels in the eye. Unlike small molecule drugs or eye drops these treatments must be injected into the eye once every 1 or 2 months. Resistance can develop to these drugs causing the disease to progress anew. • Laser surgery – to destroy abnormal blood vessels in the eye. This type of surgery is only suitable if blood vessel damage is not too extensive and if the abnormal blood vessels aren't close to the fovea, as performing surgery close to this part of the eye can cause permanent vision loss. • With DMO, Corticosteroids either injected or implanted into the eye, may be used alone or in combination with other drugs or laser surgery to treat DMO. *source: https://nei.nih.gov/health/diabetic/retinopathy
Undo Ltd. specializes in developing advanced debugging tools aimed at enhancing software development processes for professionals such as developers, software architects, and product managers. The company offers innovative solutions like LiveRecorder, which records and replays software execution, allowing users to identify and resolve programming errors effectively. Additionally, UndoDB serves as an interactive reversible debugger for C/C++ applications on Linux and Android platforms. By employing time travel debugging technology, Undo enables developers to gain insights into complex code, facilitating the diagnosis of new regressions, legacy bugs, and flaky tests prior to customer impact. The company primarily caters to industries including data management, networking, electronic design automation, and finance. Founded in 2005, Undo Ltd. operates from its headquarters in Cambridge, United Kingdom, and maintains an additional office in San Francisco, California.
Psyomics is engaged in the development of proteomic diagnostics aimed at improving the early diagnosis and treatment outcomes for individuals with neuropsychiatric disorders. The company offers a web-based assessment triage system that integrates digital profiling with advancements in biological research to enhance diagnostic accuracy. This approach assists primary care practitioners in effectively managing their patients' mental health needs by replicating a psychiatric assessment at the initial point of contact. By doing so, Psyomics facilitates improved recovery outcomes for patients suffering from mental health disorders.
Plumis Limited is a London-based company that specializes in designing and manufacturing innovative fire suppression systems. Founded in 2008, the company has developed Automist Smartscan, a modern alternative to traditional fire sprinklers, which has been installed over 10,000 times in the UK and the US. Automist operates automatically using a ceiling-mounted detector and requires significantly less water than conventional systems, reducing potential water damage. Its installation process is less intrusive, utilizing flexible hosing that minimizes plumbing requirements and avoids ceiling fittings. Plumis targets homeowners, landlords, fire inspectors, and other stakeholders through a network of installers and resellers, catering to both residential renovations and new builds. The company has gained recognition for its innovation, recently winning the 'Innovation of the Year' award at the Make UK Manufacturing Awards.
Spectral Edge is a technology company focused on developing advanced image processing and enhancement solutions. It utilizes patented image fusion technology combined with deep learning to improve the quality and visibility of images, particularly for individuals with color vision deficiencies. By leveraging the full spectrum of color, Spectral Edge's technology enables the display of multi-modal images that enhance detail and clarity without introducing artifacts. This innovation aims to benefit application developers and enhance the user experience across mass-market devices, allowing for richer and more accessible visual content.
Repositive Ltd operates an online platform that facilitates access to human genomic data for researchers and organizations. The platform aggregates metadata from various genomic datasets worldwide, enabling users to discover available data and manage their data sources. It supports data visibility within the research community and fosters collaboration through secure, privacy-preserving mechanisms. Additionally, Repositive provides a range of services including data scouting, access applications, policy reviews, and the establishment of data catalogues. The company also offers the PDX Consortium, aimed at developing pre-competitive resources for patient-derived xenograft molecular data. Founded in 2013 and based in Cambridge, United Kingdom, Repositive was previously known as Nucleobase Limited before rebranding in 2015.
Axol Bioscience Ltd. is a biotechnology company based in Little Chesterford, United Kingdom, specializing in human cell culture systems for disease modeling and drug discovery. It offers a range of products including iPSC-derived cells such as cardiomyocytes, neural stem cells, and various primary cells like endothelial and liver cells. The company also supplies essential media and growth supplements needed for cell culture, alongside disease models for conditions such as Alzheimer's and Parkinson's diseases. In addition to its product offerings, Axol provides custom services including cell and tissue sourcing, iPSC reprogramming, differentiation, and genome editing. Its products and services are distributed globally, reaching markets in North America, Asia, and Europe. Established in 2012, Axol operates from the Chesterford Research Park, known for its focus on innovation in the life sciences sector.
Tripism Ltd. is a travel platform based in Cambridge, United Kingdom, that caters to corporate travel programs and the informational needs of travel managers. Founded in 2014, it facilitates business and frequent travelers in sharing recommendations, tips, and plans within their trusted networks. The platform allows users to review and exchange insights about accommodations, dining, meeting venues, and leisure activities, thereby enhancing the travel experience for professionals. By enabling the storage and dissemination of travel opinions, Tripism aims to streamline the planning process for corporate travel, making it more efficient and informed.
Dogtooth is a technology start-up based in Cambridge that specializes in developing robotic solutions for soft fruit picking. The company has created advanced intelligent robots capable of navigating rows of strawberries and raspberries. These robots are designed to detect and locate ripe fruit, pick it efficiently, and check its quality before placing it into punnets. By automating the harvesting process, Dogtooth's technology enables fruit harvesting businesses to move away from traditional hand-picking methods, ultimately saving time and improving operational efficiency.
Cambridge Mask Co specializes in the manufacture and distribution of high-performance consumer pollution masks that utilize advanced filter technology originally developed for military applications in chemical, nuclear, and biological warfare. Their masks are designed to filter nearly 100% of viruses, bacteria, gases, and particulate matter, providing effective protection against air pollution. Available in various sizes and patterns to accommodate families, these masks have gained recognition and are supplied to notable clients, including the United Nations and British Airways. The company's commitment to health and safety is reflected in its use of military-grade filtration technology, which incorporates activated carbon cloth to ensure optimal protection for users.
Converge specializes in providing hardware and software solutions for the collection, storage, and analysis of sensor data, primarily serving the medical and construction industries. The company develops transmitters that connect to both digital and analog sensors, transforming them into wireless networked devices. Additionally, Converge offers a software platform designed to store, analyze, and visualize the data generated by these sensors. Their solutions facilitate data connectivity in hospitals, allowing healthcare professionals to manipulate and visualize patient data, which helps tailor treatments and optimize discharge processes. Converge is headquartered in London, United Kingdom, and is focused on advancing wireless sensor networks for the industrial Internet of Things, replacing manual monitoring with automated, continuous data collection and analytics.
Oxford Space Systems Limited, founded in 2013 and based in Harwell, United Kingdom, specializes in the development, manufacture, and marketing of deployable hardware structures for space environments. The company focuses on creating innovative deployable antennas, panels, hinge systems, and composite linear boom systems, utilizing advanced design techniques such as origami and proprietary materials. These technologies aim to produce structures that are lighter, less complex, and more cost-effective than traditional alternatives, catering to the global satellite industry. Oxford Space Systems has gained recognition for its rapid product development, notably with its AstroTube Boom, which achieved successful deployment in under 30 months. The company has engaged in various co-development projects supported by the UK government, collaborating with leading European satellite manufacturers and securing commercial contracts in Asia and the US. With a growing team of professionals possessing extensive experience in the space sector, Oxford Space Systems operates from a custom facility at the Harwell Space Cluster, equipped to handle defense and security contracts.
The Outside View is a predictive analytics company that has developed an algorithm to predict which houses.
PatientSource is a developer of clinical software and electronic medical record systems aimed at enhancing patient safety and quality of care. The platform facilitates the secure transmission of patient information, including referrals and discharge letters, through various communication methods such as secure emails and instant messaging. By integrating clinical pathways with multidisciplinary teams, PatientSource seeks to reduce clinician burnout and frustration, ultimately improving the overall efficiency of healthcare delivery.
TransparentChoice Ltd. provides a collaborative online decision-making software designed to enhance strategic alignment and improve project outcomes for organizations. Founded in 2013 and based in Cambridge, United Kingdom, the company's software as a service solution enables teams to structure complex decisions, gather meaningful input, and analyze data effectively. By facilitating collaboration among multidisciplinary teams, TransparentChoice helps organizations prioritize projects based on how well they align with strategic goals. This structured approach to decision-making fosters stronger buy-in from stakeholders and ultimately aids in delivering greater value from project portfolios.
Vantage Power Ltd. specializes in designing and manufacturing electric and hybrid systems for buses and heavy-duty vehicles. Founded in 2011 and based in London, the company provides a range of hybrid and electric powertrain solutions, including hybrid battery systems, drive systems, range extenders, and custom battery solutions. Vantage Power focuses on retrofitting existing buses with hybrid powertrains, allowing operators to significantly reduce fuel consumption and emissions without the high costs associated with acquiring new hybrid vehicles. The company's engineering team, which includes experts from the heavy-duty vehicle, Formula 1, and aerospace sectors, is dedicated to creating innovative solutions that ensure optimal performance, fuel efficiency, and reliability. Additionally, Vantage Power offers technologies related to system design, telemetry, control systems, and battery management. As of 2019, Vantage Power operates as a subsidiary of Allison Transmission Holdings, Inc.
Captive Media Ltd is a British company that specializes in developing and managing an interactive entertainment system designed for washrooms, particularly targeting male users. The company offers a patented urinal-mounted gaming console that features networked digital video screens displaying a mix of engaging content and advertisements. The system utilizes infra-red sensors to detect a user's stream, allowing them to control interactive games without physical contact with the screen. Games include activities such as trivia quizzes, slalom skiing, and racing, designed to capitalize on the average dwell time of 55 seconds at urinals. The units are retrofitted into existing washroom facilities and require only power and internet connections, making them suitable for installation in bars, clubs, hotels, sports venues, and shopping malls throughout the UK and EU. Captive Media also collaborates with brands and agencies to promote responsible drinking and branded products through its innovative advertising platform, which is reinforced to an industrial grade and is both waterproof and vandal-proof.
Arachnys provides cloud-based solutions for assessing financial crime customer risk and CDD, KYC, and EDD compliance. It consolidates valuable business information from emerging markets to help companies increase opportunities and reduce risk in complex but attractive markets like India, China, Russia, and the Middle East. Emerging markets are seeing an explosion of business information coming online, but information is fragmented, badly organized, and often unsearchable. Current business information providers' models focus on easy-to-obtain data but do not allow for the extraction of important data locked into siloed corporate and governmental datasets. Arachnys uses domain expertise from the security and investigative industry alongside innovative spidering and scraping technology to identify high-value information buried in the deep web and make it searchable and accessible to businesses - investment banks, hedge funds, law firms, accountants, and risk consultancies - who are increasingly looking to emerging markets for growth.
Plumis Limited is a London-based company that specializes in designing and manufacturing innovative fire suppression systems. Founded in 2008, the company has developed Automist Smartscan, a modern alternative to traditional fire sprinklers, which has been installed over 10,000 times in the UK and the US. Automist operates automatically using a ceiling-mounted detector and requires significantly less water than conventional systems, reducing potential water damage. Its installation process is less intrusive, utilizing flexible hosing that minimizes plumbing requirements and avoids ceiling fittings. Plumis targets homeowners, landlords, fire inspectors, and other stakeholders through a network of installers and resellers, catering to both residential renovations and new builds. The company has gained recognition for its innovation, recently winning the 'Innovation of the Year' award at the Make UK Manufacturing Awards.